Dr. @ertrunnell.bsky.social thanks for posting. While there is much yet to do, think in not too distant future #GigaTIME will have a major impact in tailoring therapies to patients with #cancer #GSK #Astrazeneca #Regeneron #Abbvie #incyte #FDA #NCI #FinishCancer
Led by @hoifungpoon.bsky.social & @shengwanguw.bsky.social, @chanwoo-kim.bsky.social, @bernardafox.bsky.social et al. conducted the first-ever population-scale study of the tumor immune microenvironment based on spatial #proteomics.
In @cp-cellstemcell.bsky.social:
www.cell.com/cell/fulltex...
In @cp-cellstemcell.bsky.social:
www.cell.com/cell/fulltex...
Multimodal AI generates virtual population for tumor microenvironment modeling
GigaTIME leverages multimodal AI to generate virtual multiplex immunofluorescence
(mIF) profiles from standard H&E slides, enabling comprehensive tumor immune microenvironment
modeling across a large ...
www.cell.com
December 24, 2025 at 5:50 AM
Dr. @ertrunnell.bsky.social thanks for posting. While there is much yet to do, think in not too distant future #GigaTIME will have a major impact in tailoring therapies to patients with #cancer #GSK #Astrazeneca #Regeneron #Abbvie #incyte #FDA #NCI #FinishCancer
Prof. Richard Wahl redefines #Theranostics & shows how #PET can be used to identify response and prevent over-treatment #Malinckodt #Institute of #Radiology #FinishCancer #ASTRO2025
June 4, 2025 at 7:34 PM
Prof. Richard Wahl redefines #Theranostics & shows how #PET can be used to identify response and prevent over-treatment #Malinckodt #Institute of #Radiology #FinishCancer #ASTRO2025
More #THERANOSTICS -
Prof Richard Wahl #MalinckrodtInstitute #MIR gives a bit more history on the topic. 1st iodine-labelled #monoclonal #antibodies. #FDG #ASTRO2025 #FinishCancer @uwiscradiology.bsky.social
Prof Richard Wahl #MalinckrodtInstitute #MIR gives a bit more history on the topic. 1st iodine-labelled #monoclonal #antibodies. #FDG #ASTRO2025 #FinishCancer @uwiscradiology.bsky.social
June 4, 2025 at 7:24 PM
More #THERANOSTICS -
Prof Richard Wahl #MalinckrodtInstitute #MIR gives a bit more history on the topic. 1st iodine-labelled #monoclonal #antibodies. #FDG #ASTRO2025 #FinishCancer @uwiscradiology.bsky.social
Prof Richard Wahl #MalinckrodtInstitute #MIR gives a bit more history on the topic. 1st iodine-labelled #monoclonal #antibodies. #FDG #ASTRO2025 #FinishCancer @uwiscradiology.bsky.social
#Theranostics can cure some patients? Here is an example of a patient with metastatic #ThyroidCancer that has long-term disease-free survival / @mskcancercenter.bsky.social #ASTRO2025 #FinishCancer
June 4, 2025 at 6:45 PM
#Theranostics can cure some patients? Here is an example of a patient with metastatic #ThyroidCancer that has long-term disease-free survival / @mskcancercenter.bsky.social #ASTRO2025 #FinishCancer
THERANOSTICS
WHAT IS IT? Answer below..
Why should you care?? It is improving outcomes for men with #prostate #cancer - #Pluvicto
#Bayer #Novartis #FinishCancer #ASTRO2025 #PCF @prostatecanceruk.bsky.social @ipcr.bsky.social @ip-london.bsky.social #CRUK @cruk-mi.bsky.social @prostates.bsky.social
WHAT IS IT? Answer below..
Why should you care?? It is improving outcomes for men with #prostate #cancer - #Pluvicto
#Bayer #Novartis #FinishCancer #ASTRO2025 #PCF @prostatecanceruk.bsky.social @ipcr.bsky.social @ip-london.bsky.social #CRUK @cruk-mi.bsky.social @prostates.bsky.social
June 4, 2025 at 6:35 PM
THERANOSTICS
WHAT IS IT? Answer below..
Why should you care?? It is improving outcomes for men with #prostate #cancer - #Pluvicto
#Bayer #Novartis #FinishCancer #ASTRO2025 #PCF @prostatecanceruk.bsky.social @ipcr.bsky.social @ip-london.bsky.social #CRUK @cruk-mi.bsky.social @prostates.bsky.social
WHAT IS IT? Answer below..
Why should you care?? It is improving outcomes for men with #prostate #cancer - #Pluvicto
#Bayer #Novartis #FinishCancer #ASTRO2025 #PCF @prostatecanceruk.bsky.social @ipcr.bsky.social @ip-london.bsky.social #CRUK @cruk-mi.bsky.social @prostates.bsky.social
🧐???? #THERANOSTICS ????
Looking forward to hearing the first two keynotes at THERANOSTICS conference being held at the new #Discovery building at @uwiscradiology.bsky.social @uwiscpress.bsky.social
#cancer #radiation #Therapy #ASTRO #FinishCancer #Pluvicto #Novartis #PCF #ProstateCancer
Looking forward to hearing the first two keynotes at THERANOSTICS conference being held at the new #Discovery building at @uwiscradiology.bsky.social @uwiscpress.bsky.social
#cancer #radiation #Therapy #ASTRO #FinishCancer #Pluvicto #Novartis #PCF #ProstateCancer
June 4, 2025 at 6:27 PM
🧐???? #THERANOSTICS ????
Looking forward to hearing the first two keynotes at THERANOSTICS conference being held at the new #Discovery building at @uwiscradiology.bsky.social @uwiscpress.bsky.social
#cancer #radiation #Therapy #ASTRO #FinishCancer #Pluvicto #Novartis #PCF #ProstateCancer
Looking forward to hearing the first two keynotes at THERANOSTICS conference being held at the new #Discovery building at @uwiscradiology.bsky.social @uwiscpress.bsky.social
#cancer #radiation #Therapy #ASTRO #FinishCancer #Pluvicto #Novartis #PCF #ProstateCancer
💥🦊🎶 WORK HARD/PLAY HARD! Today at #AACR2025 was closed out by #checkpoints closing song, “Don’t Stop Believin” /it resonates with me - not only because I was born & raised in #Detroit (& NW suburbs) but because songs message - Believin we can #cure #cancer @sitcancer.bsky.social #FinishCancer
April 28, 2025 at 6:46 AM
💥🦊🎶 WORK HARD/PLAY HARD! Today at #AACR2025 was closed out by #checkpoints closing song, “Don’t Stop Believin” /it resonates with me - not only because I was born & raised in #Detroit (& NW suburbs) but because songs message - Believin we can #cure #cancer @sitcancer.bsky.social #FinishCancer
Heading 2 #AACR2025 #Chicago to talk about our work on combination #cancer #immunotherapy for #HNSCC & see what is exciting scientists from across the globe. Also looking forward to visiting @loyolachicago.bsky.social Cancer Center to talk with Prof. Michael Nishimura regarding: TCR #FinishCancer
April 25, 2025 at 1:12 PM
Heading 2 #AACR2025 #Chicago to talk about our work on combination #cancer #immunotherapy for #HNSCC & see what is exciting scientists from across the globe. Also looking forward to visiting @loyolachicago.bsky.social Cancer Center to talk with Prof. Michael Nishimura regarding: TCR #FinishCancer
💥 #CELL #THERAPY IN ACTION!! A Diverse & Dynamic group of the people moving the field!! #MoffittBOB #PagonaHealth @iovancebio.bsky.social #Genicity #Galapagos #avencell #Cellares #cancer #immunotherapy #CART #TIL / #Moffitt ROCKS IT with a great program! #SurgeryBranch #NCI #FinishCancer
April 11, 2025 at 6:10 PM
💥 #CELL #THERAPY IN ACTION!! A Diverse & Dynamic group of the people moving the field!! #MoffittBOB #PagonaHealth @iovancebio.bsky.social #Genicity #Galapagos #avencell #Cellares #cancer #immunotherapy #CART #TIL / #Moffitt ROCKS IT with a great program! #SurgeryBranch #NCI #FinishCancer
Dr @patrickhwumd.bsky.social #Moffitt CEO opens #moffittBOB - with statement “This is where the magic will happen” - “How many lives will be saved because of what happens here today!” #FinishCancer #immunotherapy www.ubivac.com #cancer #DarkGenome #DarkMatter #AI
April 11, 2025 at 2:24 PM
Dr @patrickhwumd.bsky.social #Moffitt CEO opens #moffittBOB - with statement “This is where the magic will happen” - “How many lives will be saved because of what happens here today!” #FinishCancer #immunotherapy www.ubivac.com #cancer #DarkGenome #DarkMatter #AI
On Day 1 of 2025 want to thank @oncodaily for shout out & share their post. While early, this is promising news for patients with head & neck #cancer #HNSCC /lots of people responsible Drs. Rom Leidner @rbryanbell.bsky.social @walterurba.bsky.social #FinishCancer #UbiVac #Incyte
t.co/bO0JC32H5A
t.co/bO0JC32H5A
https://oncodaily.com/insight/211553
t.co
January 2, 2025 at 4:26 AM
On Day 1 of 2025 want to thank @oncodaily for shout out & share their post. While early, this is promising news for patients with head & neck #cancer #HNSCC /lots of people responsible Drs. Rom Leidner @rbryanbell.bsky.social @walterurba.bsky.social #FinishCancer #UbiVac #Incyte
t.co/bO0JC32H5A
t.co/bO0JC32H5A
@Aruthak.bsky.social Yes! The #JEDIs are Innovating & JOE YEONG is pulling us together & time not issue 4 this dedicated group still on a hi from #multiomics2024 /10pm #UK, 6am #Singapore & #Taipei, 8am #AU , 2pm #OR #SpatialMedicine #SpatialCatchUps #SpatialInnovation #FinishCancer #cancer
December 19, 2024 at 5:57 AM
@Aruthak.bsky.social Yes! The #JEDIs are Innovating & JOE YEONG is pulling us together & time not issue 4 this dedicated group still on a hi from #multiomics2024 /10pm #UK, 6am #Singapore & #Taipei, 8am #AU , 2pm #OR #SpatialMedicine #SpatialCatchUps #SpatialInnovation #FinishCancer #cancer
2) Prof Tullia Bruno #B Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases / #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
December 7, 2024 at 11:29 AM
2) Prof Tullia Bruno #B Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases / #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
Prof Tullia Bruno #B_Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases /soon 2 b submitted/ #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
December 7, 2024 at 11:26 AM
Prof Tullia Bruno #B_Cell GURU @ #UPMC reviews #TLS & then dives into “DO NOT POST” differences in TLS btwn #melanoma & #LungCancer brain #metastases /soon 2 b submitted/ #Bridge2024 @sitcancer.bsky.social @robertferrismdphd.bsky.social #FinishCancer
3) Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL /The 96% 10 yr survival of TIL pts achieving CR needs us to understand better/the Need for Biopsy
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
December 7, 2024 at 10:52 AM
3) Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL /The 96% 10 yr survival of TIL pts achieving CR needs us to understand better/the Need for Biopsy
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
2) Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL / this post mostly showing #melanoma #Brain #metastases TIL plus future steps /
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
December 7, 2024 at 10:48 AM
2) Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL / this post mostly showing #melanoma #Brain #metastases TIL plus future steps /
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL / this post mostly showing #melanoma #Brain #metastases TIL plus future steps /
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
December 7, 2024 at 10:47 AM
Dr Allison Betof Warner @DrBetofMDPHD #Stanford talks #TIL / this post mostly showing #melanoma #Brain #metastases TIL plus future steps /
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
#Bridge2024 #FinishCancer @melanomaau.bsky.social @melanomaresearch.bsky.social @impactmelanoma.bsky.social #MRF @sitcancer.bsky.social
2) Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
December 7, 2024 at 10:14 AM
2) Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
December 7, 2024 at 10:11 AM
Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & #Swiss #Cancer Center talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JoeYeong #JEDIcouncil #Bridge2024 @sitcancer.bsky.social #multiomics @aruthak.bsky.social #USCAP #AI #DigitalPathology #FinishCancer
3) GREAT DEBATE! Prof. Ryan Sullivan @danafarber.bsky.social debates with Prof. Olivier Michelin @ #Geneva Univ Cancer Center/ if #IrAE are associated with better outcome! / endocrine & Derm IrAE Strong assoc with response/ #Bridge2024 @sitcancer.bsky.social #cancer #immunotherapy #FinishCancer
December 6, 2024 at 12:18 PM
3) GREAT DEBATE! Prof. Ryan Sullivan @danafarber.bsky.social debates with Prof. Olivier Michelin @ #Geneva Univ Cancer Center/ if #IrAE are associated with better outcome! / endocrine & Derm IrAE Strong assoc with response/ #Bridge2024 @sitcancer.bsky.social #cancer #immunotherapy #FinishCancer
Discussion of Prof Mitch Levesque data / Amazing single cell #melanoma phenotypes/ can it explain resistance? Thinks metabolic signature? Functional data more important
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
December 6, 2024 at 10:05 AM
Discussion of Prof Mitch Levesque data / Amazing single cell #melanoma phenotypes/ can it explain resistance? Thinks metabolic signature? Functional data more important
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
4) 1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma understanding failure of small molecules / #targeted #therapy/ new tu phenotypes/ sc mel phenotypes/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
December 6, 2024 at 10:02 AM
4) 1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma understanding failure of small molecules / #targeted #therapy/ new tu phenotypes/ sc mel phenotypes/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
3) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
December 6, 2024 at 9:57 AM
3) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
2) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
December 6, 2024 at 9:56 AM
2) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
December 6, 2024 at 9:55 AM
1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto